Critical Care | Articles in Volume 12 Suppl 4

Skip to main content

Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Issue navigator

[2008 - Volume 12]

[ Suppl 4 ]

2007 - Volume 11

2006 - Volume 10

2005 - Volume 9

2004 - Volume 8

2003 - Volume 7

2002 - Volume 6

2001 - Volume 5

2000 - Volume 4

1999 - Volume 3

1998 - Volume 2

1997 - Volume 1

Most recent articles

Contents of Volume 12 Suppl 4

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Reviews

Edited by Stephan Harbarth

Publication of this supplement has been sponsored by Ortho-McNeil, Inc.

Additional information

Introduction

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Reuben Ramphal
Critical Care 2008, 12(Suppl 4):S1 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]

Review

Pharmacodynamic optimization of -lactams in the patient care setting
David P Nicolau
Critical Care 2008, 12(Suppl 4):S2 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review

An overview of harms associated with -lactam antimicrobials: where do the carbapenems fit in?
Robert C Owens Jr
Critical Care 2008, 12(Suppl 4):S3 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review

Gram-negative antibiotic resistance: there is a price to pay
Thomas G Slama
Critical Care 2008, 12(Suppl 4):S4 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review

The role of carbapenems in initial therapy for serious Gram-negative infections
James J Rahal
Critical Care 2008, 12(Suppl 4):S5 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

	Critical Care
	BioMed Central
	Current Controlled Trials
	PubMed
	PubMed Central

© 1999-2008 BioMed Central Ltd unless otherwise stated < info@ccforum.com > Terms and conditions